发明名称 Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate.
摘要 The invention relates to calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-ÄÄ(4-aminophenyl)sulfonylÜ(isobutyl)amin oÜ-1-benzyl-2-(phosphonooxy) propylcarbamate combined with the HIV protease inhibitor 10-hydroxy-2-methyl-5-(1-methylethyl)-1-Ä2-(1-methylethyl)4-thiazolylÜ -3,6-dioxo-8,1 1-bis(phenylmethyl)-2,4,7,12-tetraazatridecan-13-oic acid, 5-thiazolylmethyl ester (ritonavir), and to the use thereof in the treatment of diseases caused by retroviruses. <CHEM>
申请公布号 ZA200100417(B) 申请公布日期 2002.02.27
申请号 ZA20010000417 申请日期 2001.01.15
申请人 GLAXO GROUP LIMITED 发明人 IAN GORDON ARMITAGE;HARDEV SINGH;ANDREW DAVID SEARLE
分类号 A61K31/665;A61K38/55;A61P31/12;A61P31/14;A61P31/18;A61P37/04;C07F9/655 主分类号 A61K31/665
代理机构 代理人
主权项
地址